Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
19 October 2022 | Story Leonie Bolleurs
Dr Pieter du Toit
Dr Pieter du Toit, President of the Convocation, recently addressed more than 200 Convocation members at the Annual General Meeting.

What if you knew there was a body whose endeavours sought to be dynamic and engaging, promote excellence, welcome inclusion, and serve its alma mater?

One of the aims of the UFS Convocation – a body of more than 40 000 members – is to pay close attention to and engage on matters pertaining to governance, administration, and academic affairs at the University of the Free State (UFS).

This entity seeks to ensure that the research outputs of the university are communicated in a positive light, and that feedback is provided to ensure that the current academic programmes are adequate to enhance graduate employability. Among their goals is to provide a forum for unemployed graduates to share their skills, expertise, and abilities.

Furthermore, this body attempts to establish dialogue around social issues and ongoing transformation.

 

Fostering a spirit of belonging

According to Dr Pieter du Toit, President of the UFS Convocation, it is important for this structure that it stays relevant to its members and society and that it fosters a spirit of belonging. He recently addressed members on the UFS Bloemfontein Campus at the Annual General Meeting, the first to be held in the past two years. Besides the in-person attendance, the meeting was also attended by more than 200 members via livestream.

Dr Du Toit explained to members – which, according to legislation, include all persons who have obtained a formal qualification from the UFS, as well as all permanent academic staff members that the Convocation strives to promote a positive image of the UFS, advancing and safeguarding its reputation.

Also speaking at the AGM was the UFS Rector and Vice-Chancellor, Prof Francis Petersen. He reflected on the state of the UFS, talking about the past five years to date. He touched on matters pertaining to the core functions of the university, including teaching and learning, research and internationalisation, and engaged scholarship.

As stated in its vision, the UFS strives to be a research-led, student-centred, and regionally engaged university in Bloemfontein, the Free State, South Africa, and the continent.

In the past five years, the UFS’ framework of guidance has been the Integrated Transformation Plan, which endeavoured to emphasise social justice; the UFS Strategic Plan, the focus of which was to enhance the scope of transformation by following a holistic approach; and the Vice-Chancellor’s Strategic projects, aimed at creating a high-performance institution. “To be able to do what you need to do, you have to be at the top of your game,” said Prof Petersen.

In addition, the UFS has also been guided by the University Risk Management Committee and the Institutional Multi-stakeholder Group, which is a safe space that impacts the progression of an inclusive culture of belonging at the UFS.

Prof Petersen also referred to the 2020/2021 period during the COVID-19 pandemic. “There were three imperatives to which the UFS was committed during this period – the health and safety of staff and students, ensuring that no staff member or student was left behind, and successfully completing the 2020/2021 academic year,” stated Prof Petersen.

According to him, the university has engaged in different strategies to ensure that students were not left behind academically, and that committed staff did not overextend themselves. “We have dealt with it in such a way that our success rate for undergraduate studies has improved, which indicates the resilience of our students and the commitment of our staff,” he said.

The UFS is one of the nation's top universities for student success.

 

Optimising our research capacity

Two of the research successes of this year were an increase in research outputs and in the number of postgraduate students. The university is also working towards increasing the number of academic staff with PhDs, as well as its number of postdoctoral fellows. “We are looking at optimising our research capacity,” stated Prof Petersen.

Regarding engaged scholarship, Prof Petersen believes that if you cannot positively impact society through teaching and learning and research, you should ask why you exist as a university.

“We as a university is in a good place and I think you can be very proud of your alma mater,” he said.

For the way forward, the university is working on Vision130 (a strategy spanning over 12 years). “The vision will be quite bold, including goals for 75% of academic staff to have obtained their PhDs, a bigger focus on the postgraduate programme, and to be one of the top-five institutions in the country and one of the top-600 in the world. We will also reduce our student numbers to around 35 000, because we believe this is the number that we should be focusing on,” stated Prof Petersen.

“As members of the Convocation, I ask you to find a place in Vision130, to see how you can contribute to make this university a better institution than it is today,” he added.

Concluding his presentation, Prof Petersen told members of the Convocation, “You are immensely important to us as a university – you are the continuity between the past and the present as well as the future.”

Full-time UFS staff and alumni are welcome to contact the President of the Convocation with suggestions at convocation@ufs.ac.za

 

 

What is the Convocation?

  • It is important for the Convocation that it stays relevant to its members and society and that it fosters a spirit of belonging for alumni by keeping the communication channels with members open.
  • The Convocation strives to promote a positive image of the UFS, advancing and safeguarding its reputation.
  • The Convocation seeks to ensure that the research outputs of the university are communicated in a positive light, and that feedback is provided to ensure that the current academic programmes are adequate to enhance graduate employability.
  • Furthermore, this body attempts to establish dialogue around social issues and ongoing transformation.
  • In addition to promoting the institution's business and community interests, this structure aims to instil respect for the UFS.
  • Its goal is to instil in alumni a sense of responsibility, obligation, and accountability towards the community in general and to their alma mater in particular.

 Who is part of the Convocation?

  • All persons who have obtained a formal qualification from the UFS, as well as all permanent academic staff members.

 How often does the Convocation meet?

  • The Convocation sees to it that members meet at least once every two years.


News Archive

Cardiology Unit involved in evaluation of drug for rare genetic disease
2013-01-04

Front from the left, are: Marinda Karsten (study coordinator and registered nurse),
Laumarie de Wet (clinical technologist), Charmaine Krahenbuhl (study coordinator and radiographer),
Lorinda de Meyer (administrator), Andonia Page (study coordinator and enrolled nurse);
back Dr Gideon Visagie (sub investigator), Dr Derick Aucamp (sub investigagtor),
Prof. Hennie Theron, (principal investigator) and Dr Wilhelm Herbst (sub investigator).
Photo: Supplied
09 January 2013


The Cardiology Research Unit at the University of the Free State (UFS) contributed largely to the evaluation of the drug Juxtapid (lomitapide), which was developed by the Aegerion pharmaceutical company and approved by the FDA (Federal Drug Administration). Together with countries such as die USA, Canada and Italy, the UFS’ Unit recruited and evaluated the most patients (5 of 29) for the study since 2008.  

The drug was evaluated in persons with so-called familial homozygous hypercholesterolemia (HoFH).  

Following its approval by the FDA, Juxtapid is now a new treatment option for patients suffering from HoFH. The drug operates in a unique way which brings about dramatic improvements in cholesterol counts.  

According to Prof. Hennie Theron, Associate Professor in the Department of Cardiology at the UFS and Head of the Cardiology Contract Research Unit, HoFH is a serious, rare genetic disease which affects the function of the receptor responsible for the removal of low-density lipoprotein cholesterol (LDL-C) (“bad” cholesterol) from the body. Damage to the LDL receptor function leads to extremely high levels of blood cholesterol. HoFH patients often develop premature and progressive atherosclerosis, which is a narrowing or blockage of the arteries.  

“HoFH is a genetically transmitted disease and the most severe form of hypercholesterolemia. Patients often need a coronary artery bypass or/and aortic valve replacement before the age of 20. Mortality is extremely high and death often occurs before the third decade of life. Existing conventional cholesterol-lowering medication is unsuccessful in achieving normal target cholesterol values in this group of patients.  

“The only modality for treatment is plasmapheresis (similar to dialysis in patients with renal failure). Even with this type of therapy the results are relatively unsatisfactory because it is very expensive and the plasmapheresis has to be performed on a regular basis.  

“The drug Juxtapid, as currently evaluated, has led to a dramatic reduction in cholesterol values and normal values were achieved in several people. No existing drug is nearly as effective.  

“The drug represents a breakthrough in the treatment of familial homozygous hypercholesterolemia. The fact that it has been approved by the FDA, gives further impetus to the findings,” says Prof. Theron.  

In future further evaluation will be performed in other forms of hypocholesterolemia.  

According to Prof. Theron, the findings of the study, as well as the recent successful FDA evaluation, once again confirms the fact that the UFS’ Cardiology Contract Research Unit is doing outstanding work.  

Since its inception in 1992, the Unit has already been involved in more than 60 multi-centre, international phase 2 and 3 drug studies. Several of these studies, including the abovementioned study, really affected the way in which cardiology functions.  

The UFS’ Cardiology Contract Research Unit is being recognised nationally and internationally for its high quality of work and is constantly approached for their involvement in new studies.  

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept